PRGO
PERRIGO Co plc
Key Financials
Revenue
$4.3B
↓ 2.8%
Operating Income
$-1122200000
↓ 1094.0%
Gross Profit
$1.5B
↓ 3.1%
Net Income
$-1425400000
↓ 729.7%
EPS (Diluted)
$-10.29
↓ 723.2%
Total Liabilities
$5.6B
↑ 5.1%
Total Assets
$8.5B
↓ 11.5%
Shareholders' Equity
$2.9B
↓ 32.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G/A | 7/29/2026 | View on SEC |
| 4 | 7/23/2026 | View on SEC |
| 4 | 7/15/2026 | View on SEC |
| 4 | 7/15/2026 | View on SEC |
| 3 | 7/14/2026 | View on SEC |
| 3 | 7/10/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PRGO |
| Company Name | PERRIGO Co plc |
| CIK | 1585364 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L2 |
| Phone | 269-673-8451 |